Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Can Bitcoin Maintain the Latest Rally? Experts Express Mixed Reactions
  2. Hibbett Shares Rally On Better-than-estimated Earnings, Increased Outlook
  3. Bloomberg Strategist on $ETH vs $BTC: “Ethereum’s Upper Hand Could Be Enduring”
  4. NuScale Power Rallies After Standard Power Selecting Its SMR Technology
  5. One of South Africa’s Largest Supermarket Chains Now Supports Bitcoin Payments